Following the recent research published on the COVID-19 vaccination’s effect on cancer patients, we’ve received an increase in enquiries from people affected by WM, specifically about whether you should be worried about the amount of time between the doses. We spoke to Consultant Haematologists and WM experts, Dr Dima El-Sharkawi and Dr Shirley D’Sa, for the latest advice for WM patients.
Dr Jaimal Kothari is a WMUK trustee, clinical lead for the late phase clinical trials group, and Consultant Haematologist at Oxford University Hospitals. He spent some time with us, talking about what his average day looks like.
From 1 April, the Government has told people who are ‘clinically extremely vulnerable’ that they will no longer have to shield. We understand that this may be a worrying time, and have put together some advice for people coming out of shielding.
A recent study suggests that blood cancer patients might not have a good response to the first dose of the COVID-19. We understand that this might make worrying reading for many WM patients, their friends and family. We're here to help you understand what this means for you.